BR0108723A - Medicamentos contra doenças viróticas - Google Patents
Medicamentos contra doenças viróticasInfo
- Publication number
- BR0108723A BR0108723A BR0108723-1A BR0108723A BR0108723A BR 0108723 A BR0108723 A BR 0108723A BR 0108723 A BR0108723 A BR 0108723A BR 0108723 A BR0108723 A BR 0108723A
- Authority
- BR
- Brazil
- Prior art keywords
- viral diseases
- against viral
- medicines against
- isoxazoles
- medicines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/14—Nitrogen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
"MEDICAMENTOS CONTRA DOENçAS VIRóTICAS". A invenção refere-se a isoxazóis que são agentes antivirais altamente eficazes. Combinações de isoxazóis, dihidropirimidinas e/ou lamivudin e eventualmente interferona inibem a multiplicação de vírus HBV melhor do que os agentes conhecidos até agora
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2000109408 DE10009408A1 (de) | 2000-02-28 | 2000-02-28 | Arzneimittel gegen virale Erkrankungen |
DE2000132874 DE10032874A1 (de) | 2000-07-06 | 2000-07-06 | Arzneimittelkombinationen gegen virale Erkrankungen |
PCT/EP2001/001825 WO2001064755A2 (de) | 2000-02-28 | 2001-02-19 | Isoxazole gegen virale erkrankungen |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0108723A true BR0108723A (pt) | 2002-12-03 |
Family
ID=26004561
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0108723-1A BR0108723A (pt) | 2000-02-28 | 2001-02-19 | Medicamentos contra doenças viróticas |
Country Status (13)
Country | Link |
---|---|
US (1) | US20030187028A1 (pt) |
EP (1) | EP1286974A2 (pt) |
JP (1) | JP2003526639A (pt) |
KR (1) | KR20020079963A (pt) |
CN (1) | CN1406233A (pt) |
AU (1) | AU3739801A (pt) |
BR (1) | BR0108723A (pt) |
CA (1) | CA2401405A1 (pt) |
IL (1) | IL151188A0 (pt) |
MX (1) | MXPA02008418A (pt) |
PL (1) | PL365124A1 (pt) |
TR (1) | TR200201954T2 (pt) |
WO (1) | WO2001064755A2 (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030236287A1 (en) * | 2002-05-03 | 2003-12-25 | Piotrowski David W. | Positive allosteric modulators of the nicotinic acetylcholine receptor |
CA2633400A1 (en) * | 2005-12-15 | 2007-06-21 | Bayer Healthcare Ag | Diaryl urea for treating virus infections |
US20130267517A1 (en) | 2012-03-31 | 2013-10-10 | Hoffmann-La Roche Inc. | Novel 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection |
CN104144924B (zh) * | 2012-03-31 | 2016-02-24 | 弗·哈夫曼-拉罗切有限公司 | 用于治疗和预防乙型肝炎病毒感染的4-甲基-二氢嘧啶类 |
EP2953945A2 (en) * | 2013-02-07 | 2015-12-16 | Tobira Therapeutics, Inc. | Lamivudine salts |
CN109970675A (zh) * | 2018-05-28 | 2019-07-05 | 中国医学科学院医药生物技术研究所 | 一组硫脲化合物及其制备方法和应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2126329A (en) * | 1936-03-20 | 1938-08-09 | Hoffmann La Roche | Amide derivatives of isoxazole carboxylic acids |
ATE143262T1 (de) * | 1992-12-29 | 1996-10-15 | Abbott Lab | Inhibitoren der retroviralen protease |
DE69937904T2 (de) * | 1998-03-11 | 2009-01-02 | James W. Oak Park Williams | Antivirale verwendungen von leflunomid produkten |
-
2001
- 2001-02-19 IL IL15118801A patent/IL151188A0/xx unknown
- 2001-02-19 WO PCT/EP2001/001825 patent/WO2001064755A2/de not_active Application Discontinuation
- 2001-02-19 EP EP01909773A patent/EP1286974A2/de not_active Withdrawn
- 2001-02-19 BR BR0108723-1A patent/BR0108723A/pt not_active Application Discontinuation
- 2001-02-19 AU AU37398/01A patent/AU3739801A/en not_active Abandoned
- 2001-02-19 TR TR2002/01954T patent/TR200201954T2/xx unknown
- 2001-02-19 KR KR1020027011205A patent/KR20020079963A/ko not_active Application Discontinuation
- 2001-02-19 PL PL01365124A patent/PL365124A1/xx not_active Application Discontinuation
- 2001-02-19 JP JP2001564248A patent/JP2003526639A/ja active Pending
- 2001-02-19 MX MXPA02008418A patent/MXPA02008418A/es unknown
- 2001-02-19 US US10/220,110 patent/US20030187028A1/en not_active Abandoned
- 2001-02-19 CA CA002401405A patent/CA2401405A1/en not_active Abandoned
- 2001-02-19 CN CN01805765A patent/CN1406233A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2001064755A3 (de) | 2002-06-20 |
EP1286974A2 (de) | 2003-03-05 |
CA2401405A1 (en) | 2001-09-07 |
WO2001064755A2 (de) | 2001-09-07 |
PL365124A1 (en) | 2004-12-27 |
AU3739801A (en) | 2001-09-12 |
JP2003526639A (ja) | 2003-09-09 |
IL151188A0 (en) | 2003-04-10 |
KR20020079963A (ko) | 2002-10-21 |
US20030187028A1 (en) | 2003-10-02 |
TR200201954T2 (tr) | 2002-12-23 |
CN1406233A (zh) | 2003-03-26 |
MXPA02008418A (es) | 2003-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1265889T3 (da) | Lægemidler imod virussygdomme | |
AP1782A (en) | Use of compounds ?-D or ?-L nucleoside for treating hepatitis C virus. | |
ES2135062T3 (es) | Pirazolo y pirrolopiridinas. | |
BRPI0411900A (pt) | compostos antivirais e métodos | |
DK0821690T3 (da) | Nukleotidanaloger til behandling af virusinfektioner | |
ATE245641T1 (de) | Antivirale pyrimidinderivate | |
AU2003291998A8 (en) | Method and compositions for identifying anti-hiv therapeutic compounds | |
AP1771A (en) | 3'-Prodrugs of 2'-deoxy-?-L-nucleosides. | |
WO1995000638A3 (en) | Antisense oligonucleotides and therapeutic use thereof in human immunodeficiency virus infection | |
DK1280813T3 (da) | Antivirale pyrimidin-nukleosidanaloger | |
ES2051641B1 (es) | Procedimientos para la preparacion de compuestos derivados de tiourea. | |
IL145884A0 (en) | Anti-hiv 1 vaccine comprising the entire or part of the tat hiv-1 protein | |
BR9913333A (pt) | Inibição e tratamento do vìrus da hepatite b e flavivìrus com helioxatina e seus análogos | |
BR0111729A (pt) | 1-aril-4-oxo-1,4-dihidro-3-quinolinacarboxamidas como agentes antivirais | |
BR0108723A (pt) | Medicamentos contra doenças viróticas | |
BR0111393A (pt) | Métodos de tratamento de doenças virais com il-18 e suas combinações | |
AP2049A (en) | Medicament containing activated antithrombin III | |
NO965556L (no) | Trippelkombinasjon mot HIV | |
FI951078A (fi) | Retrovirusinfektion inhibitio | |
NO20021856L (no) | Koplingsdal | |
DE69937904D1 (de) | Antivirale verwendungen von leflunomid produkten | |
ATE108832T1 (de) | Verwendung von monoklonalen antikörpern gegen b2- mikroglobulin. | |
NO982151L (no) | Hemoregulatoriske forbindelser | |
ITRM940405A0 (it) | "composti inibitori dello sviluppo di virus hiv, loro preparazione e usi". | |
UA38786A (uk) | Фібринолітичний засіб |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |